Exchange: NASDAQ Sector: Healthcare Industry: Medical Devices
0.00% $22.58
America/New_York / 31 des 1970 @ 19:00
RATING 2022-02-09 |
---|
B+ |
Buy |
RATINGS | ||
---|---|---|
Rating CashFlow: | Strong Buy | |
Return On Equity: | Neutral | |
Return On Asset: | Neutral | |
DE: | Neutral | |
P/E: | Strong Sell | |
Price To Book: | Strong Buy |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
2/20 | 3/20 | 4/20 | 1/21 | 2/21 | 3/21 | |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Gr.Profit | n/a | n/a | n/a | n/a | n/a | n/a |
Ebit | ||||||
Asset | ||||||
Debt | n/a | n/a | n/a | n/a | n/a | n/a |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE 0 | sector: PE -3.05 |
PE RATIO: COMPANY / INDUSTRY |
---|
N/A |
Company: PE 0 | industry: PE 222.16 |
DISCOUNTED CASH FLOW VALUE |
---|
N/A |
N/A |
Expected Trading Range (DAY) |
---|
$ 22.20 - 22.96 ( +/- 1.69%) |
ATR Model: 14 days |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2021-12-16 | Klemp Walter V | Sell | 84 500 | Stock option (right to buy) |
2021-12-16 | Klemp Walter V | Sell | 425 000 | Common Stock |
2021-12-16 | Klemp Walter V | Sell | 35 150 | Stock option (right to buy) |
2021-12-16 | Klemp Walter V | Sell | 89 300 | Stock option (right to buy) |
2021-12-16 | Klemp Walter V | Sell | 113 000 | Stock option (right to buy) |
INSIDER POWER |
---|
0.00 |
Last 52 transactions |
Buy: 1 215 200 | Sell: 2 366 984 |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 | |
MACD |
Volume Signals | |
---|---|
Price | $22.58 (0.00% ) |
Volume | 1.347 mill |
Avg. Vol. | 0.183 mill |
% of Avg. Vol | 736.81 % |
Signal 1: | |
Signal 2: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % |
---|
Soliton, Inc., a medical device company, develops and commercializes products using a proprietary rapid acoustic pulse technology platform. The company offers products for the removal of tattoos. It also develops a product for cellulite reduction, fibrotic scar treatment, and other indications. The company was incorporated in 2012 and is based in Houston, Texas. As of December 16, 2021, Soliton, Inc. operates as a subsidiary of Allergan plc.